2024
Internal tremors and vibrations in long COVID: a cross-sectional study
Zhou T, Sawano M, Arun A, Caraballo C, Michelsen T, McAlpine L, Bhattacharjee B, Lu Y, Khera R, Huang C, Warner F, Herrin J, Iwasaki A, Krumholz H. Internal tremors and vibrations in long COVID: a cross-sectional study. The American Journal Of Medicine 2024 PMID: 39069199, DOI: 10.1016/j.amjmed.2024.07.008.Peer-Reviewed Original ResearchNew-onset conditionsInternal tremorLong COVID symptomsCOVID symptomsNon-Hispanic whitesCross-sectional studyQuality of lifeVisual analogue scaleWorse healthHealth statusStudy participantsDemographic characteristicsAnalogue scaleOutcome variablesNeurological conditionsLong COVIDMast cell disordersTreatment experienceHealthComorbiditiesSymptomsMedian agePeopleCell disorders1087 Recognizing Sleep Disorders in the US Military Health System: Differences Between On-base and Private Sector Care
Capaldi V, Williams S, Thomas C, Herrin J, Hong A, Funk W, Collen J, Stryckman B, Albrecht J, Wickwire E. 1087 Recognizing Sleep Disorders in the US Military Health System: Differences Between On-base and Private Sector Care. Sleep 2024, 47: a467-a467. DOI: 10.1093/sleep/zsae067.01087.Peer-Reviewed Original ResearchObstructive sleep apneaMilitary Data RepositoryMilitary Health System beneficiariesSleep disordersMilitary Health SystemBetween-group differencesUS Military Health SystemSleep carePsychiatric comorbiditiesPrivate sector careRecognize sleep disordersComorbid sleep disordersICD-10 diagnostic codesSleep apneaClinical characteristicsDiagnosis of insomniaDiagnostic codesBetween-groupDirect careComorbiditiesInsomniaDisordersSleepICD-10Active duty personnel
2016
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006–2013
Lipska KJ, Yao X, Herrin J, McCoy RG, Ross JS, Steinman MA, Inzucchi SE, Gill TM, Krumholz HM, Shah ND. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006–2013. Diabetes Care 2016, 40: 468-475. PMID: 27659408, PMCID: PMC5360291, DOI: 10.2337/dc16-0985.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedBlood GlucoseComorbidityDiabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsDrug UtilizationFemaleGlycated HemoglobinHumansHypoglycemiaHypoglycemic AgentsInsulinLogistic ModelsMaleMetforminMiddle AgedRetrospective StudiesSulfonylurea CompoundsThiazolidinedionesYoung AdultConceptsGlycemic controlSevere hypoglycemiaOlder patientsDipeptidyl peptidase-4 inhibitorsGlucose-lowering drugsGlucose-lowering medicationsProportion of patientsOverall glycemic controlPeptidase-4 inhibitorsMedicare Advantage patientsSex-standardized ratesType 2 diabetesOverall rateClass of agentsMore comorbiditiesChronic comorbiditiesYounger patientsAdvantage patientsDrug utilizationClaims dataPatientsHypoglycemiaHemoglobin AT2DMComorbidities
2010
Improvements in US Maternal Obstetrical Outcomes From 1992 to 2006
Srinivas SK, Epstein AJ, Nicholson S, Herrin J, Asch DA. Improvements in US Maternal Obstetrical Outcomes From 1992 to 2006. Medical Care 2010, 48: 487-493. PMID: 20393363, DOI: 10.1097/mlr.0b013e3181d68840.Peer-Reviewed Original ResearchConceptsMajor maternal complicationsMaternal complicationsCesarean deliveryVaginal deliveryObstetrical outcomesHospital discharge dataPopulation-based sampleRisk-adjusted ratesThrombotic complicationsCD patientsVD patientsMajor complicationsObstetric proceduresHospital careDelivery outcomesCommon reasonComplicationsPatientsComorbiditiesWomenOutcomesAverage numberComposite measureCD ratesDischarge data